• Hillhouse Capital pays RMB2.3b to up stake in Chinese pharma Asymchem

    Hillhouse Capital closes another deal in boosting the innovation of China’s pharmaceutical industry.
    On the evening of February 16, Asymchem (002821) announced the termination of the non-public offering of shares in 2019, and disclosed the 2020 non-public offering of shares. The company intends to issue non-public shares of no more than 18.7 million shares at 123.56 apiece. The total amount will